Immucura Med S.L.(Mijas, Spain)

Immucura Med S.L. is a service provider in south Spain for cancer treatment with autologous Dendritic Cell therapy, also known as cancer vaccine or Immunotherapy. The Dendritic Cell therapy offered by us, was developed in cooperation with the University of Nuremberg. It has been implemented in clinical studies which can be requested.

Rockefeller University cell biologist Ralph M. Steinman, who discovered the immune system\'s sentinel dendritic cells and demonstrated that science can fruitfully harness the power of these cells and other components of the immune system to curb infections and other communicable diseases, was a recipient of the 2011 Nobel Prize in Physiology or Medicine, announced by the Nobel Foundation in Stockholm, Sweden.

It is recent research and clinical studies which show the huge potential of fighting serious diseases with a Dendritic Cells Vaccine. The first FDA (U.S. Food & Drug Administration) approval for a Dendritic Cells Vaccine was given in 2010. Nowadays doctors around the globe urge to apply the Dendritic Cell therapy at any stage of cancer due to numerous positive test results. Although the accessibility to this kind of treatment is still very limited, since only a few laboratories and doctors are specialized in the Dendritic Cells Therapy, Immucura Med aims to bring the Therapy to patients around the globe, starting with the Costa del Sol.

The Dendritic Cells therapy can be applied as first line therapy and parallel to other therapies or treatments. Meaning that the Dendritic Cell therapy can be applied complementary or as alternative to chemotherapy and/or radiotherapy as well as in post-treatment or for prevention.

1. The patient contacts Immucura Med

2. An expert doctor proceeds to study the patient\'s case and informs the patient about the therapy.

3. With the patient\'s consent, a blood sample is taken and sent to our laboratory in Germany. All laboratory works are proceeded under GMP guidelines, international standards and state-of-the-art technology.

4. There Dendritic Cells get isolated from the sample and multiplied. Now they get loaded with the corresponding antigen and pieces of proteins matching the ones of the malicious cells of the disease. The whole process takes around 10 days.

5. After these 10 days the patient has a further appointment to the specialized Doctor and the vaccination is applied.

6. The immune system responds immediately by sending T lymphocytes as well as NK-cells, which then recognize exactly the malicious cancer cells and give them the order to eliminate themselves.

7. During the first days after the vaccination the patient might have a sensation of tiredness, but shortly after this he/she will notice the vitalizing and healing effect of the Dendritic Cells in his/her body.

By now almost all clinical tests showed no or only very little negative side effects. Approximately 80% of the patients, who were given DC showed different positive results. Furthermore, Patients who were treated with DCs experienced an increase of life quality and lifespan.

Immucura Med cooperates with physicians, oncologist and clinics. Our partners are able to offer you further therapies besides the Dendritic Cell Therapy: Hyperthermia, nutritional consultation, oncological psychology and conventional cancer therapies. All therapeutical approaches can be coordinated with your doctor of confidence.

We provide doctors access to our file with publication of clinical trials with Dendritic Cells, which were conducted all over the world.

Feel free to ask us any question that might occur to you via WhatClinic.